Russell Investments Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Sell |
52,136
-23,205
| -31% | -$726K | ﹤0.01% | 1824 |
|
|
2025
Q1 | $2.53M | Sell |
75,341
-138,355
| -65% | -$4.64M | ﹤0.01% | 1556 |
|
|
2024
Q4 | $8.38M | Sell |
213,696
-9,918
| -4% | -$389K | 0.01% | 898 |
|
|
2024
Q3 | $8.8M | Buy |
223,614
+60,764
| +37% | +$2.39M | 0.01% | 890 |
|
|
2024
Q2 | $6.35M | Sell |
162,850
-15,249
| -9% | -$595K | 0.01% | 1037 |
|
|
2024
Q1 | $7.67M | Buy |
178,099
+3,813
| +2% | +$164K | 0.01% | 959 |
|
|
2023
Q4 | $8.03M | Buy |
174,286
+4,898
| +3% | +$226K | 0.01% | 896 |
|
|
2023
Q3 | $5.79M | Buy |
169,388
+18,932
| +13% | +$647K | 0.01% | 1015 |
|
|
2023
Q2 | $5.79M | Buy |
150,456
+65,098
| +76% | +$2.51M | 0.01% | 1031 |
|
|
2023
Q1 | $3.05M | Buy |
85,358
+1,028
| +1% | +$36.8K | 0.01% | 1341 |
|
|
2022
Q4 | $3.33M | Sell |
84,330
-14,744
| -15% | -$581K | 0.01% | 1303 |
|
|
2022
Q3 | $3.58M | Sell |
99,074
-8,825
| -8% | -$319K | 0.01% | 1245 |
|
|
2022
Q2 | $3.28M | Buy |
107,899
+33,980
| +46% | +$1.03M | 0.01% | 1315 |
|
|
2022
Q1 | $2.26M | Buy |
73,919
+21,748
| +42% | +$664K | ﹤0.01% | 1578 |
|
|
2021
Q4 | $1.63M | Buy |
+52,171
| New | +$1.63M | ﹤0.01% | 1909 |
|
|
2020
Q1 | – | Sell |
-24,460
| Closed | -$320K | – | 3155 |
|
|
2019
Q4 | $320K | Sell |
24,460
-12,544
| -34% | -$164K | ﹤0.01% | 2556 |
|
|
2019
Q3 | $332K | Sell |
37,004
-46,276
| -56% | -$415K | ﹤0.01% | 2432 |
|
|
2019
Q2 | $821K | Buy |
83,280
+78,679
| +1,710% | +$776K | ﹤0.01% | 2066 |
|
|
2019
Q1 | $47K | Buy |
4,601
+389
| +9% | +$3.97K | ﹤0.01% | 2806 |
|
|
2018
Q4 | $27K | Buy |
+4,212
| New | +$27K | ﹤0.01% | 2849 |
|